B. Riley Estimates InfuSystem’s Q2 Earnings (NYSE:INFU)

InfuSystem Holdings, Inc. (NYSE:INFU) – Stock analysts at B. Riley dropped their Q2 2025 earnings per share estimates for shares of InfuSystem in a research report issued to clients and investors on Tuesday, March 4th. B. Riley analyst K. Bauser now forecasts that the company will post earnings per share of $0.05 for the quarter, down from their previous estimate of $0.06. The consensus estimate for InfuSystem’s current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem’s FY2025 earnings at $0.23 EPS.

Separately, StockNews.com lowered shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a report on Thursday.

InfuSystem Stock Up 0.3 %

Shares of NYSE:INFU opened at $6.25 on Thursday. InfuSystem has a fifty-two week low of $5.74 and a fifty-two week high of $9.97. The firm’s 50 day moving average price is $7.96 and its 200 day moving average price is $7.60. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market cap of $132.90 million, a price-to-earnings ratio of 104.18 and a beta of 1.75.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its position in shares of InfuSystem by 66.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock valued at $27,000 after purchasing an additional 1,626 shares during the period. Wells Fargo & Company MN increased its stake in InfuSystem by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company’s stock valued at $78,000 after buying an additional 3,165 shares during the period. Legato Capital Management LLC purchased a new stake in shares of InfuSystem in the fourth quarter valued at about $85,000. Summit Global Investments purchased a new position in InfuSystem during the fourth quarter worth about $86,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in InfuSystem during the 3rd quarter worth approximately $87,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.